MarketPeel
Insider Trading Intelligence
MG

Michelle Renee Griffin

ADPT
DIRECTOR · ADAPTIVE BIOTECHNOLOGIES CORP · CIK 0001229765
FILING MIX · LIFETIME40%/60%
BUYS
27
SELLS
40
TOTAL VALUE
$7.04M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
0
AVG SELL PX
$24.21
TRADE KIND
SHOWING 67 / 67
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
24 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Michelle Renee Griffin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d24+45.83%+0.35%+0.02%+0.33%+0.30%
14d24+50.00%-1.41%+0.02%-1.43%+2.23%
30d24+58.33%-1.24%+1.63%-2.87%-4.54%
60d24+54.17%-1.27%+5.19%-6.46%-8.32%
90d24+70.83%-3.83%+7.59%-11.33%-16.33%
180d24(2 pending)+90.91%-21.36%+13.27%-34.63%-42.45%
1y24(2 pending)+90.91%-49.34%+15.11%-64.44%-78.69%
2y24(4 pending)+100.00%-78.96%+9.03%-87.99%-89.74%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ADPT · 0 shares · as of Jun 25, 2026
028,25056,50084,750113,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 27 buys / 40 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
52,084$7.80$406.3K67,709Jun 25, 2026Jun 29, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE10b5-1
10b5-1 plan
52,084$20.18$1.05M15,625Jun 25, 2026Jun 29, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
52,0840Jun 25, 2026Jun 29, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
15,394$13.91$214.1K15,625Mar 11, 2026Mar 13, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
15,62531,019Mar 4, 2026Mar 6, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
48,044$3.99$191.7K63,438Mar 3, 2026Mar 5, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
48,0440Mar 3, 2026Mar 5, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE10b5-1
10b5-1 plan
48,044$15.30$735.1K15,394Mar 3, 2026Mar 5, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
36,291$7.19$260.9K15,394Mar 13, 2025Mar 17, 2025View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE10b5-1
10b5-1 plan
15,664$7.94$124.4K51,685Mar 6, 2025Mar 6, 2025View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
15,39467,349Mar 4, 2025Mar 6, 2025View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
23,72623,726Mar 4, 2025Mar 6, 2025View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
31,32851,955Mar 4, 2024Mar 6, 2024View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
48,04448,044Mar 4, 2024Mar 6, 2024View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,341$8.49$19.9K20,627Mar 27, 2023Mar 29, 2023View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
14,77522,968Mar 6, 2023Mar 8, 2023View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
23,32923,329Mar 6, 2023Mar 8, 2023View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
16,72216,722Jan 26, 2022Jan 28, 2022View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
6,6898,193Jan 26, 2022Jan 28, 2022View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
14,91652,084Aug 27, 2021Aug 30, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
14,916$35.00$522.1K1,504Aug 27, 2021Aug 30, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
14,916$7.80$116.3K16,420Aug 27, 2021Aug 30, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,500$7.80$19.5K4,004Jul 14, 2021Jul 19, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,50067,000Jul 14, 2021Jul 19, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,500$36.80$92.0K1,504Jul 14, 2021Jul 19, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
4,00069,500Jun 17, 2021Jun 21, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
4,000$7.80$31.2K5,504Jun 17, 2021Jun 21, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
4,000$40.00$160.0K1,504Jun 17, 2021Jun 21, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,500$7.80$19.5K4,004Jun 14, 2021Jun 16, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,50073,500Jun 14, 2021Jun 16, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,500$38.56$96.4K1,504Jun 14, 2021Jun 16, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,500$35.00$87.5K1,504May 18, 2021May 19, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,500$7.80$19.5K4,004May 18, 2021May 19, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,50076,000May 18, 2021May 19, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
4,50078,500Apr 14, 2021Apr 16, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
4,500$7.80$35.1K6,004Apr 14, 2021Apr 16, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
4,500$43.41$195.3K1,504Apr 14, 2021Apr 16, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,50083,000Mar 16, 2021Mar 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
1,500$7.80$11.7K3,004Mar 16, 2021Mar 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,500$47.00$70.5K1,504Mar 16, 2021Mar 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
4,500$7.80$35.1K6,004Mar 15, 2021Mar 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
3,609$41.89$151.2K1,504Mar 15, 2021Mar 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
4,50084,500Mar 15, 2021Mar 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
891$41.17$36.7K5,113Mar 15, 2021Mar 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
6,00089,000Feb 16, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
6,000$7.80$46.8K7,504Feb 16, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
6,000$65.08$390.5K1,504Feb 16, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
1,5041,504Feb 14, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
3,7593,759Feb 14, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
6,000$7.80$46.8K6,000Jan 14, 2021Jan 15, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
6,00095,000Jan 14, 2021Jan 15, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
5,041$65.77$331.5K959Jan 14, 2021Jan 15, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
959$66.43$63.7K0Jan 14, 2021Jan 15, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,651$59.44$98.1K0Dec 14, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
6,000$7.80$46.8K6,000Dec 14, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
3,367$58.96$198.5K1,651Dec 14, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
982$57.42$56.4K5,018Dec 14, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
6,000101,000Dec 14, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
5,021$47.57$238.8K979Nov 16, 2020Nov 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
6,000$7.80$46.8K6,000Nov 16, 2020Nov 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
979$48.30$47.3K0Nov 16, 2020Nov 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
6,000107,000Nov 16, 2020Nov 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
12,000$7.80$93.6K12,000Oct 14, 2020Oct 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
12,000113,000Oct 14, 2020Oct 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
7,351$53.07$390.1K0Oct 14, 2020Oct 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
4,649$52.48$244.0K7,351Oct 14, 2020Oct 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
8,8888,888Feb 13, 2020Feb 18, 2020View →
Other insiders · ADPT
Loading peer insiders…
About this filer
CIK 0001229765
ROLE
Director
PRIMARY
ADPT
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001229765DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback